{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T07:05:24Z","timestamp":1763363124344,"version":"3.45.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIGMS-RISE R25","award":["GM061838"],"award-info":[{"award-number":["GM061838"]}]},{"name":"Henry Ford Health + Michigan State University Health Sciences Grant"},{"name":"RCMI Seed Monies and Professional Development Award","award":["U54 MD007600"],"award-info":[{"award-number":["U54 MD007600"]}]},{"name":"The American Society of Pharmacognosy","award":["Starter Grant"],"award-info":[{"award-number":["Starter Grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23480-3","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:54:22Z","timestamp":1762973662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Majusculamide-o, a simplified marine natural product analog, exhibits potent and specific cancer cell cytotoxicity"],"prefix":"10.1038","volume":"15","author":[{"given":"Niklas Alexander","family":"Wahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiara","family":"Lebr\u00f3n-Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"P\u00e9rez-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Hernandez-Mejias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Leshchiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick A.","family":"Valeriote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo J. E.","family":"Caro-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachi","family":"Horibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"23480_CR1","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. American Cancer Society www.seer.cancer.gov (2025)."},{"key":"23480_CR2","unstructured":"Cancer Facts & Figures 2024. American Cancer Society https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2024-cancer-facts-figures.html."},{"key":"23480_CR3","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1245\/s10434-021-10401-7","volume":"28","author":"G Belfiori","year":"2021","unstructured":"Belfiori, G. et al. Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival. Ann. Surg. Oncol. 28, 8249\u20138260 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"23480_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1245\/s10434-008-0295-2","volume":"16","author":"MHG Katz","year":"2009","unstructured":"Katz, M. H. G. et al. Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma. Ann. Surg. Oncol. 16, 836 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"23480_CR5","unstructured":"Survival Rates for Pancreatic Cancer. American Cancer Society https:\/\/www.cancer.org\/cancer\/types\/pancreatic-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"key":"23480_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41571-024-00883-1","volume":"21","author":"SG Huayamares","year":"2024","unstructured":"Huayamares, S. G., Loughrey, D., Kim, H., Dahlman, J. E. & Sorscher, E. J. Nucleic acid-based drugs for patients with solid tumours. Nat. Rev. Clin. Oncol. 21, 407\u2013427 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"23480_CR7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/genes13081370","volume":"13","author":"M Butt","year":"2022","unstructured":"Butt, M. et al. Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review. Genes 13, 1370 (2022).","journal-title":"Genes"},{"key":"23480_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/nadc.20224127280","volume":"70","author":"G Dorm\u00e1n","year":"2022","unstructured":"Dorm\u00e1n, G. The rise, fall and revival of combinatorial chemistry. Nachrichten Aus Chem. 70, 70\u201372 (2022).","journal-title":"Nachrichten Aus Chem."},{"key":"23480_CR9","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1038\/s41467-023-39949-6","volume":"14","author":"Looking back and moving forward in medicinal chemistry","year":"2023","unstructured":"Looking back and moving forward in medicinal chemistry. Nat. Commun. 14, 4299 (2023).","journal-title":"Nat. Commun."},{"key":"23480_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.synbio.2020.05.003","volume":"5","author":"Y Tong","year":"2020","unstructured":"Tong, Y. & Deng, Z. An aurora of natural products-based drug discovery is coming. Synth. Syst. Biotechnol. 5, 92\u201396 (2020).","journal-title":"Synth. Syst. Biotechnol."},{"key":"23480_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"advances and opportunities","year":"2021","unstructured":"advances and opportunities. the International Natural Product Sciences Taskforce, Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery. Nat. Rev. Drug Discov. 20, 200\u2013216 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"23480_CR12","unstructured":"Mayer, A. M. S. Marine Pharmacology. https:\/\/www.marinepharmacology.org\/approved."},{"key":"23480_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/md20120759","volume":"20","author":"SA Dyshlovoy","year":"2022","unstructured":"Dyshlovoy, S. A. & Honecker, F. Marine compounds and cancer: updates 2022. Mar. Drugs 20, 759 (2022).","journal-title":"Mar. Drugs"},{"key":"23480_CR14","doi-asserted-by":"publisher","unstructured":"Antunes, E. M. et al. Medicines from the sea. in Oceans and Human Health 103\u2013148 (Elsevier, 2023). https:\/\/doi.org\/10.1016\/B978-0-323-95227-9.00009-9.","DOI":"10.1016\/B978-0-323-95227-9.00009-9"},{"key":"23480_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/md20080494","volume":"20","author":"I Cheng-S\u00e1nchez","year":"2022","unstructured":"Cheng-S\u00e1nchez, I., Moya-Utrera, F., Porras-Alcal\u00e1, C., L\u00f3pez-Romero, J. M. & Sarabia, F. Antibody-drug conjugates containing payloads from marine origin. Mar. Drugs 20, 494 (2022).","journal-title":"Mar. Drugs"},{"key":"23480_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1021\/jo00085a006","volume":"59","author":"WH Gerwick","year":"1994","unstructured":"Gerwick, W. H. et al. Structure of curacin a, a novel antimitotic, antiproliferative and brine shrimp toxic natural product from the marine cyanobacterium lyngbya majuscula. J. Org. Chem. 59, 1243\u20131245 (1994).","journal-title":"J. Org. Chem."},{"key":"23480_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1021\/acsmedchemlett.7b00192","volume":"8","author":"W Cai","year":"2017","unstructured":"Cai, W., Chen, Q.-Y., Dang, L. H. & Luesch, H. Apratoxin S10, a dual inhibitor of angiogenesis and cancer cell growth to treat highly vascularized tumors. ACS Med. Chem. Lett. 8, 1007\u20131012 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"23480_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejmech.2018.10.024","volume":"161","author":"J Almaliti","year":"2019","unstructured":"Almaliti, J. et al. Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents. Eur. J. Med. Chem. 161, 416\u2013432 (2019).","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"23480_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.chembiol.2016.04.008","volume":"23","author":"AO Paatero","year":"2016","unstructured":"Paatero, A. O. et al. Apratoxin kills cells by direct blockade of the Sec61 protein translocation channel. Cell Chem. Biol. 23(5), 561\u2013566 (2016).","journal-title":"Cell Chem. Biol."},{"key":"23480_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202416210","volume":"63","author":"C Dessin","year":"2024","unstructured":"Dessin, C. et al. Highly Cytotoxic Cryptophycin Derivatives with Modification in Unit D for Conjugation. Angew. Chem. Int. Ed. 63, e202416210 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"23480_CR21","first-page":"3779","volume":"54","author":"CD Smith","year":"1994","unstructured":"Smith, C. D., Zhang, X., Mooberry, S. L., Patterson, G. M. & Moore, R. E. Cryptophycin: A new antimicrotubule agent active against drug-resistant cells. Cancer Res. 54, 3779\u20133784 (1994).","journal-title":"Cancer Res."},{"key":"23480_CR22","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1016\/0031-9422(88)80008-6","volume":"27","author":"RE Moore","year":"1988","unstructured":"Moore, R. E. & Entzeroth, M. Majusculamide D and Deoxymajusculamide Toxins From Lyngbya Majuscula D. Two Cyto-. Phyochemistry 27, 3101\u20133103 (1988).","journal-title":"Two Cyto-. Phyochemistry"},{"key":"23480_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/np50083a009","volume":"55","author":"FE Koehn","year":"1992","unstructured":"Koehn, F. E., Longley, R. E. & Reed, J. K. Microcolins A and B, new immunosuppressive peptides from the blue-green alga Lyngbya majuscula. J. Nat. Prod. 55, 613\u2013619 (1992).","journal-title":"J. Nat. Prod."},{"key":"23480_CR24","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41589-022-01061-z","volume":"18","author":"F-L Li","year":"2022","unstructured":"Li, F.-L. et al. Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides. Nat. Chem. Biol. 18, 1076\u20131086 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"23480_CR25","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1021\/acs.jnatprod.9b00549","volume":"82","author":"H-B Yu","year":"2019","unstructured":"Yu, H.-B. et al. Cytotoxic Microcolin Lipopeptides from the Marine Cyanobacterium Moorea producens. J. Nat. Prod. 82, 2608\u20132619 (2019).","journal-title":"J. Nat. Prod."},{"key":"23480_CR26","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1055\/s-0029-1185675","volume":"75","author":"T Meickle","year":"2009","unstructured":"Meickle, T., Matthew, S., Ross, C., Luesch, H. & Paul, V. Bioassay-Guided Isolation and Identification of Desacetylmicrocolin B from Lyngbya cf. polychroa. Planta Med. 75, 1427\u20131430 (2009).","journal-title":"Planta Med."},{"key":"23480_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1021\/acs.orglett.8b04050","volume":"21","author":"EJE Caro-Diaz","year":"2019","unstructured":"Caro-Diaz, E. J. E., Valeriote, F. A. & Gerwick, W. H. Highly convergent total synthesis and assignment of absolute configuration of Majusculamide D, a potent and selective cytotoxic metabolite from moorea sp. Org. Lett. 21, 793\u2013796 (2019).","journal-title":"Org. Lett."},{"issue":"6","key":"23480_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cjoc.202300526","volume":"42","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Synthesis of anti-pancreatic cancer natural product majusculamide D and analogues reveals a preliminary structure-activity relationships. Chinese J. Chem. 42(6), 605\u2013610 (2024).","journal-title":"Chinese J. Chem."},{"key":"23480_CR29","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1021\/jm00045a024","volume":"37","author":"FE Koehn","year":"1994","unstructured":"Koehn, F. E., McConnell, O. J., Longley, R. E., Sennett, S. H. & Reed, J. K. Analogs of the marine immunosuppressant microcolin A: Preparation and biological activity. J. Med. Chem. 37, 3181\u20133186 (1994).","journal-title":"J. Med. Chem."},{"key":"23480_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41392-023-01667-2","volume":"8","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITP\u03b1\/\u03b2. Signal Transduct. Target. Ther. 8, 428 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"23480_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/md22120537","volume":"22","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Structure-activity relationship study of majusculamide D: Overcoming metabolic instability and severe toxicity with a fluoro analogue. Mar. Drugs 22, 537 (2024).","journal-title":"Mar. Drugs"},{"key":"23480_CR32","first-page":"5379","volume":"43","author":"TC Hamilton","year":"1983","unstructured":"Hamilton, T. C. et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43, 5379\u20135389 (1983).","journal-title":"Cancer Res."},{"key":"23480_CR33","unstructured":"The Human Protein Atlas. Ovarian cancer https:\/\/www.proteinatlas.org\/humanproteome\/cell+line\/ovarian+cancer (2025)."},{"key":"23480_CR34","first-page":"581","volume":"62","author":"R Blanco","year":"2012","unstructured":"Blanco, R. et al. Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target. Acta Pharm. Zagreb Croat. 62, 581\u2013591 (2012).","journal-title":"Acta Pharm. Zagreb Croat."},{"key":"23480_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cam4.219","volume":"3","author":"A Torsvik","year":"2014","unstructured":"Torsvik, A. et al. U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med. 3, 812\u2013824 (2014).","journal-title":"Cancer Med."},{"key":"23480_CR36","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3892\/ol.2013.1623","volume":"6","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. Identification of U251 glioma stem cells and their heterogeneous stem-like phenotypes. Oncol. Lett. 6, 1649\u20131655 (2013).","journal-title":"Oncol. Lett."},{"key":"23480_CR37","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.3390\/ijms222313135","volume":"22","author":"VA Arzumanian","year":"2021","unstructured":"Arzumanian, V. A., Kiseleva, O. I. & Poverennaya, E. V. The curious case of the HepG2 cell line: 40 years of expertise. Int. J. Mol. Sci. 22, 13135 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"23480_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ijc.2910150505","volume":"15","author":"M Lieber","year":"1975","unstructured":"Lieber, M., Mazzetta, J., Nelson-Rees, W., Kaplan, M. & Todaro, G. Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas. Int. J. Cancer 15, 741\u2013747 (1975).","journal-title":"Int. J. Cancer"},{"key":"23480_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1021\/ol990573k","volume":"1","author":"H Li","year":"1999","unstructured":"Li, H. et al. 3-(Diethoxyphosphoryloxy)-1,2,3- benzotriazin-4(3 H )-one (DEPBT): A New Coupling Reagent with Remarkable Resistance to Racemization. Org. Lett. 1, 91\u201394 (1999).","journal-title":"Org. Lett."},{"key":"23480_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/bip.20201","volume":"80","author":"Y Ye","year":"2005","unstructured":"Ye, Y., Li, H. & Jiang, X. DEPBT as an efficient coupling reagent for amide bond formation with remarkable resistance to racemization. Pept. Sci. 80, 172\u2013178 (2005).","journal-title":"Pept. Sci."},{"key":"23480_CR41","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1039\/D1GC04387K","volume":"24","author":"L Ferrazzano","year":"2022","unstructured":"Ferrazzano, L. et al. Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges. Green Chem. 24, 975\u20131020 (2022).","journal-title":"Green Chem."},{"key":"23480_CR42","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.1002\/chem.200900615","volume":"15","author":"A El-Faham","year":"2009","unstructured":"El-Faham, A., Funosas, R. S., Prohens, R. & Albericio, F. COMU: A safer and more effective replacement for benzotriazole-based uronium coupling reagents. Chem. Eur. J. 15, 9404\u20139416 (2009).","journal-title":"Chem. Eur. J."},{"key":"23480_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41419-024-06712-8","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Li, X., Yang, M. & Liu, S.-B. Research progress on morphology and mechanism of programmed cell death. Cell Death Dis. 15, 327 (2024).","journal-title":"Cell Death Dis."},{"key":"23480_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"23480_CR45","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"23480_CR46","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. Publ. Protein Soc. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"23480_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He, Y. et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct. Target. Ther. 6, 425 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"23480_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar, M. E., Kim, H. J. & Kim, D. R. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: From mechanism to clinical studies. Signal Transduct. Target. Ther. 8, 455 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"23480_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-025-01234-0","author":"KF Harvey","year":"2025","unstructured":"Harvey, K. F. & Tang, T. T. Targeting the Hippo pathway in cancer. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-025-01234-0 (2025).","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23480-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T07:03:24Z","timestamp":1763363004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23480-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23480"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23480-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39727"}}